SC
ALMS

Stempoint Capital’s Alumis Inc ALMS Stock Holding History

Stempoint Capital’s Portfolio ALMS Stock Details ALMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.06M Buy
+229,566
New +$5.74M 0.97% 34

Other funds holding ALMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stempoint Capital's ALMS Position: Q1 2026 in Review

Stempoint Capital opened a new position in Alumis Inc (ALMS) in Q1 2026: 229,566 shares worth $5.06M. The stake represents 0.97% of the portfolio and ranks #34 among its holdings.

195 funds tracked by Wall St. Rank hold ALMS as of Q1 2026.

  • Stempoint Capital held 229,566 shares of Alumis Inc worth $5.06M as of Q1 2026.
  • Alumis Inc was a new Stempoint Capital position in Q1 2026.
  • Alumis Inc made up 0.97% of Stempoint Capital's portfolio in Q1 2026, its #34 holding.
  • 195 funds tracked by Wall St. Rank held Alumis Inc as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.